Arxis officer Kevin Perhamus proposes $1.26M stock sale

The notice links the proposed transaction to a selling plan dated August 10, 2026, intended to comply with Rule 10b5-1(c).

Available on EDGAR 11/09/2026 - 06:38 PM EST Accepted by SEC EDGAR 11/09/2026 - 06:38 PM EST Learn about SEC filing dates

Rhea-AI Filing Summary

Arxis, Inc. officer Kevin Perhamus filed a notice of proposed sale covering 25,000 common shares, with an aggregate market value of $1,256,500 and an approximate sale date of November 9, 2026. The shares were acquired from Arxis as compensation through restricted stock awards on May 6, 2026. The proposed sale is in connection with a selling plan dated August 10, 2026, intended to comply with Rule 10b5-1(c); Goldman Sachs & Co. LLC signed on his behalf.

Key Figures

Shares to be sold: 25,000 shares Aggregate market value: $1,256,500 Shares outstanding: 90,045,099 shares

3 metrics

Shares to be sold 25,000 shares Proposed sale of common shares

Aggregate market value $1,256,500 Shares covered by the proposed sale

Shares outstanding 90,045,099 shares Issuer share count reported in the notice

Key Terms

Rule 10b5-1(c), Restricted Stock Awards, Aggregate Market Value

3 terms

Rule 10b5-1(c) regulatory

"intended to comply with Rule 10b5-1(c)"

Rule 10b5-1(c) is an SEC guideline that lets company insiders set up a written, pre-planned schedule to buy or sell their company stock when they are not in possession of material, nonpublic information. For investors, it matters because such plans can reduce the appearance of insider trading by separating decisions from inside knowledge—like putting your trades on autopilot—while also requiring scrutiny since pre-planned trades can still affect market confidence and share value.

Restricted Stock Awards financial

"Acquired as compensation -- Restricted Stock Awards"

Restricted stock awards are company shares given to employees or executives that cannot be sold or transferred until certain conditions — like staying with the company for a set time or meeting performance targets — are met, like a gift that is locked in a safe until rules are satisfied. Investors care because these awards tie management’s pay to company performance, can increase the number of shares outstanding when they become tradable (dilution), and may signal expected future selling pressure or commitment to long-term growth.

Aggregate Market Value financial

"Aggregate Market Value"

Aggregate market value is the combined price you would pay to buy all outstanding shares of a company or all companies in a group at current market prices — essentially the sum of each stock’s market capitalization. It matters to investors because it shows the overall size and weight of an investment or sector (like the total cost to buy every piece of a puzzle), helps compare scale across companies or markets, and influences index composition and risk exposure.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many ARXS shares does officer Kevin Perhamus propose to sell?

Kevin Perhamus's notice covers a proposed sale of 25,000 Arxis common shares, with an aggregate market value of $1,256,500 and an approximate sale date of November 9, 2026.

Is Kevin Perhamus's proposed ARXS sale connected to a Rule 10b5-1 plan?

The proposed sale is in connection with a selling plan dated August 10, 2026, which is intended to comply with Rule 10b5-1(c).

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0002126584
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	ARXIS, INC.
SEC File Number	001-43234
Address of Issuer	1332 Blue Hills Avenue Bloomfield CONNECTICUT 06002
Phone	1-860-243-7100
Name of Person for Whose Account the Securities are To Be Sold	Kevin Perhamus
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Shares	Goldman Sachs & Co. LLC 200 West Street New York NY 10282	25000	1256500	90045099	11/09/2026	NASD

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Shares	05/06/2026	Acquired as compensation -- Restricted Stock Awards	Arxis, Inc.			25000	05/06/2026	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks	The sales of shares set forth herein are made in connection with a selling plan dated 8/10/2026, that is intended to comply with Rule 10b5-1(c).
Date of Notice	11/09/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	08/10/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	Goldman Sachs & Co. LLC on behalf of Kevin Perhamus
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)